Document Detail


Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.
MedLine Citation:
PMID:  18021253     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Angiogenic switch in renal cell carcinoma (RCC) is attributed to the inactivation of the von Hippel-Lindau tumor suppressor, stabilization of hypoxia inducible factor-1 transcription factor and increased vascular endothelial growth factor. To evaluate the role of an angiogenesis inhibitor, thrombopsondin-1 (TSP1), we compared TSP1 production in human RCC and normal tissue and secretion by the normal renal epithelium (human normal kidney, HNK) and RCC cells. Normal and RCC tissues stained positive for TSP1, and the levels of TSP1 mRNA and total protein were similar in RCC and HNK cells. However, HNK cells secreted high TSP1, which rendered them nonangiogenic, whereas RCC cells secreted little TSP1 and were angiogenic. Western blot and immunostaining revealed TSP1 in the cytoplasm of RCC cells on serum withdrawal, whereas, in HNK cells, it was rapidly exported. Seeking mechanisms of defective TSP1 secretion, we discovered impaired calcium uptake by RCC in response to vascular endothelial growth factor. In HNK cells, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester, a calcium chelator, simulated TSP1 retention, mimicking the RCC phenotype. Further analysis revealed a profound decrease in transient receptor potential canonical ion channel 4 (TRPC4) Ca(2+) channel expression in RCC cells. TRPC4 silencing in HNK cells caused TSP1 retention and impaired secretion. Double labeling of the secretory system components revealed TSP1 colocalization with coatomer protein II (COPII) anterograde vesicles in HNK cells. In contrast, in RCC cells, TSP1 colocalized with COPI vesicles, pointing to the retrograde transport to the endoplasmic reticulum caused by misfolding. Our study indicates that TRPC4 loss in RCC leads to impaired Ca(2+) intake, misfolding, retrograde transport and diminished secretion of antiangiogenic TSP1, thus enabling angiogenic switch during RCC progression.
Authors:
Dorina Veliceasa; Marina Ivanovic; Frank Thilo-Schulze Hoepfner; Praveen Thumbikat; Olga V Volpert; Norm D Smith
Related Documents :
19377443 - Csf1r copy number changes, point mutations, and rna and protein overexpression in renal...
22549623 - Effects of 837 and 1950 mhz radiofrequency radiation exposure alone or combined on ox...
23177613 - The effects of graphene oxide nanosheets localized on f-actin filaments on cell-cycle a...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2007-11-15
Journal Detail:
Title:  The FEBS journal     Volume:  274     ISSN:  1742-464X     ISO Abbreviation:  FEBS J.     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-12-13     Completed Date:  2008-03-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101229646     Medline TA:  FEBS J     Country:  England    
Other Details:
Languages:  eng     Pagination:  6365-77     Citation Subset:  IM    
Affiliation:
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blotting, Western
COP-Coated Vesicles / drug effects,  metabolism
Calcium / metabolism,  pharmacokinetics
Carcinoma, Renal Cell / blood supply*,  pathology
Cell Line
Cell Line, Tumor
Cell Proliferation
Chelating Agents / pharmacology
Corneal Neovascularization / genetics,  metabolism,  pathology
Egtazic Acid / analogs & derivatives,  pharmacology
Female
Fluorescent Antibody Technique
Humans
Immunohistochemistry
Kidney Neoplasms / blood supply*,  pathology
Mice
Mice, Inbred C57BL
Neovascularization, Pathologic / genetics,  metabolism,  pathology*
Rats
Rats, Inbred F344
Reverse Transcriptase Polymerase Chain Reaction
TRPC Cation Channels / genetics,  metabolism
Thrombospondin 1 / genetics,  metabolism*,  secretion
Transfection
Grant Support
ID/Acronym/Agency:
R01 HL077471/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Chelating Agents; 0/TRPC Cation Channels; 0/TRPC4 ion channel; 0/Thrombospondin 1; 139890-68-9/1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester; 67-42-5/Egtazic Acid; 7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphoglu...
Next Document:  Structural and functional investigations of Ureaplasma parvum UMP kinase--a potential antibacterial ...